Literature DB >> 8029911

Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection.

M Catena1, J Woo, L A Valdivia, S Celli, F Pan, J J Fung, T E Starzl, A W Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8029911      PMCID： PMC3018884     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).

Authors:  G J Peters; S L Sharma; E Laurensse; H M Pinedo
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

2.  The antilymphocytic activity of brequinar sodium and its potentiation by cytidine. Effects on lymphocyte proliferation and cytokine production.

Authors:  J Woo; B Lemster; K Tamura; T E Starzl; A W Thomson
Journal:  Transplantation       Date:  1993-08       Impact factor: 4.939

3.  The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.

Authors:  D V Cramer; F A Chapman; B D Jaffee; E A Jones; M Knoop; G Hreha-Eiras; L Makowka
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.